Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
Clinical trial NCT01405508 · COMPLETED
Trial details
- NCT number
- NCT01405508
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-07-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.